SLAM
PRAX icon

Swiss Life Asset Management’s Praxis Precision Medicines PRAX Stock Holding History

Swiss Life Asset Management’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$510K Buy
1,522
+120
+9% +$38K ﹤0.01% 949
2026
Q1 		$452K Buy
1,402
+456
+48% +$141K ﹤0.01% 909
2025
Q4 		$279K Buy
+946
New +$176K ﹤0.01% 1065

Other funds holding PRAX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Swiss Life Asset Management's PRAX Position: Q2 2026 in Review

Swiss Life Asset Management increased its Praxis Precision Medicines (PRAX) stake by 8.6% in Q2 2026, buying an estimated $38K and bringing the position to 1,522 shares worth $510K. The position accounts for ﹤0.01% of the portfolio, ranked #949.

Swiss Life Asset Management first reported a position in PRAX in Q4 2025 and has held it in 3 quarters since. 158 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Swiss Life Asset Management held 1,522 shares of Praxis Precision Medicines worth $510K as of Q2 2026.
  • Swiss Life Asset Management bought 120 Praxis Precision Medicines shares in Q2 2026, an estimated $38K.
  • Praxis Precision Medicines made up ﹤0.01% of Swiss Life Asset Management's portfolio in Q2 2026, its #949 holding.
  • Swiss Life Asset Management first reported a position in Praxis Precision Medicines in Q4 2025 and has held it in 3 quarters since.
  • 158 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Swiss Life Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.